MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Impax Laboratories Company Profile (NASDAQ:IPXL)

Consensus Ratings for Impax Laboratories (NASDAQ:IPXL) (?)
Ratings Breakdown: 2 Sell Rating(s), 5 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Hold (Score: 2.25)
Consensus Price Target: $46.55 (5.86% upside)

Current Analysts' Coverage Summary for Impax Laboratories (NASDAQ:IPXL)
Show:
DateFirmActionRatingPrice TargetActions
8/12/2015Deutsche BankReiterated RatingHold$50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/11/2015Leerink SwannLower Price TargetMarket Perform$49.00 -> $47.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/20/2015SusquehannaInitiated CoveragePositive$60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/3/2015Raymond JamesInitiated CoverageUnderperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/2/2015Piper JaffrayReiterated RatingOverweight$58.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/23/2015RBC CapitalReiterated RatingSector Perform$37.00 -> $42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/6/2015JMP SecuritiesBoost Price TargetMarket Outperform$48.00 -> $56.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2015JPMorgan Chase & Co.Reiterated RatingHold$38.00 -> $40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2015Needham & Company LLCBoost Price TargetBuy$37.00 -> $46.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2015Goldman SachsDowngradeBuy -> Neutral$33.00 -> $41.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/9/2015WallachBeth CapitalBoost Price TargetBuy$35.00 -> $42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/5/2014Bank of AmericaReiterated RatingUnderperform$28.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/30/2014WunderlichDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/29/2014Cowen and CompanyDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/3/2014Evercore ISIBoost Price TargetHold$35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/10/2014Wells Fargo & Co.Initiated CoverageMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2014Buckingham ResearchUpgradeUnderperform -> Neutral$15.00 -> $26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/2/2014GuggenheimBoost Price Target$30.00 -> $32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/16/2014Sterne Agee CRTInitiated CoverageNeutral$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/10/2014Ned Davis ResearchUpgradeNeutral -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/13/2013Janney Montgomery ScottInitiated CoverageBuy$30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/7/2013Jefferies GroupBoost Price TargetHold$20.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/5/2013Canaccord GenuityBoost Price TargetHold$20.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/28/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha